Doliver Advisors, LP Bristol Myers Squibb CO Transaction History

Doliver Advisors, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $5,789 - $6,473	-100 Reduced 2.32%	4,203 $243,000
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $87,144 - $95,976	1,200 Added 38.67%	4,303 $331,000
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $52,995 - $63,546	-862 Reduced 21.74%	3,103 $227,000
Q4 2021 Feb 07, 2022	BUY	$53.63 - $62.52 $5,363 - $6,252	100 Added 2.59%	3,965 $258,000
Q2 2021 Aug 06, 2021	BUY	$61.91 - $67.42 $23,649 - $25,754	382 Added 10.97%	3,865 $258,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $4,594 - $5,091	80 Added 2.35%	3,483 $210,000
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $167,461 - $218,438	3,403 New	3,403 $218,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Doliver Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Doliver Advisors, LP with notifications on news.